Ohsawa M, Mogi T, Yamamoto H, Yamato I, Anraku Y
Department of Biology, Faculty of Science, University of Tokyo, Japan.
J Bacteriol. 1988 Nov;170(11):5185-91. doi: 10.1128/jb.170.11.5185-5191.1988.
Two putP mutants of Escherichia coli K-12 that were defective in proline transport but retained the binding activities of the major proline carrier were isolated (T. Mogi, H. Yamamoto, T. Nakao, I. Yamato, and Y. Anraku, Mol. Gen. Genet. 202:35-41, 1986). One of these mutations and three null-type mutations (K. Motojima, I. Yamato, and Y. Anraku, J. Bacteriol. 136:5-9, 1978) were cloned into a pBR322 putP+ hybrid plasmid (pTMP5) by in vivo recombination. Cytoplasmic membrane vesicles were prepared from the mutant strains and strains harboring pTMP5 putP plasmids, and the properties of the proline-binding reaction of the mutant putP carriers in membranes were examined under nonenergized conditions. The putP19, putP21, and putP22 mutations, which were mapped in the same DNA segment of the putP gene (Mogi et al., Mol. Gen. Genet. 202:35-41, 1986), caused the complete loss of proline carrier activity. The proline carriers encoded by the mutant putP genes, putP9 and putP32, and putP32 in pTMP5-32, which was derived from in vivo recombination with the putP32 mutation, had altered sodium ion and proton dependence of binding affinities for proline and were resistant to N-ethylmaleimide inactivation without changes in the specificities for substrates and alkaline metal cations. The nucleotide sequence of the putP32 lesion located on the 0.35-megadalton RsaI-PvuII fragment in the putP gene in pTMP5-32 was determined; the mutation changed a cytosine at position 1001 to a thymine, causing the alteration of arginine to cysteine at amino acid position 257 in the primary structure of the proline carrier. It was shown that this one point mutation was enough to produce the phenotype of pTMP5-32 by in vitro DNA replacement of the AcyI-PvuII fragment of the wild-type putP gene with the DNA fragment containing the mutated nucleotide sequence.
分离出两株大肠杆菌K-12的putP突变体,它们在脯氨酸转运方面存在缺陷,但保留了主要脯氨酸载体的结合活性(T. Mogi、H. Yamamoto、T. Nakao、I. Yamato和Y. Anraku,《分子与普通遗传学》202:35 - 41,1986年)。通过体内重组将其中一个突变以及三个无效型突变(K. Motojima、I. Yamato和Y. Anraku,《细菌学杂志》136:5 - 9,1978年)克隆到pBR322 putP⁺杂种质粒(pTMP5)中。从突变菌株和携带pTMP5 putP质粒的菌株制备细胞质膜囊泡,并在无能量条件下检测膜中突变的putP载体脯氨酸结合反应的特性。定位于putP基因同一DNA区段的putP19、putP₂₁和putP₂₂突变(Mogi等人,《分子与普通遗传学》202:35 - 41,1986年)导致脯氨酸载体活性完全丧失。由突变的putP基因putP9和putP32以及pTMP5 - 32中的putP32编码的脯氨酸载体,pTMP5 - 32是通过与putP32突变的体内重组获得的,其脯氨酸结合亲和力的钠离子和质子依赖性发生了改变,并且对N - 乙基马来酰亚胺失活具有抗性,而底物和碱金属阳离子的特异性没有变化。测定了位于pTMP5 - 32中putP基因0.35兆道尔顿RsaI - PvuII片段上的putP32损伤的核苷酸序列;该突变使第1001位的胞嘧啶变为胸腺嘧啶,导致脯氨酸载体一级结构中第257位氨基酸的精氨酸变为半胱氨酸。结果表明,通过用含有突变核苷酸序列的DNA片段体外替换野生型putP基因的AcyI - PvuII片段,这一个点突变足以产生pTMP5 - 32的表型。